Myxoid Liposarcoma
Symptoms, Doctors, Treatments, Advances & More

Myxoid Liposarcoma Overview

Save information for later
Sign Up

Learn About Myxoid Liposarcoma

What is the definition of Myxoid Liposarcoma?
Myxoid liposarcoma is a subtype of liposarcoma, tumors that arise in the body's fat tissue. Other categories of liposarcoma include well-differentiated; dedifferentiated; round cell; and pleomorphic. Round cell and Myxoid liposarcomas are sometimes grouped together into one category known as myxoid/round cell liposarcoma (MRCLS). In adults, liposarcomas are the most common type of soft tissue sarcoma. The cause of liposarcomas is not well-established but trauma has been implicated in some cases. Myxoid liposarcomas generally arise in the lower extremities. Symptoms may vary depending on the location of the tumor but may include swelling; decreased range of motion; numbness; fatigue; abdominal pain; weight loss; nausea; and vomiting. Many patients with liposarcoma have no symptoms until the tumor is large and interferes with neighboring structures.
What are the alternative names for Myxoid Liposarcoma?
  • Myxoid liposarcoma
  • MRCLS
  • Myxoid/round cell liposarcoma
  • Myxoliposarcoma
Who are the top Myxoid Liposarcoma Local Doctors?
Elite in Myxoid Liposarcoma
Dr. Sandra D'angelo
Oncology
Elite in Myxoid Liposarcoma
Dr. Sandra D'angelo
Oncology

Rockefeller Outpatient Pavilion

160 E 53rd St, 
New York, NY 
646-583-3648
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandra D'angelo is an Oncologist in New York, New York. Dr. D'angelo is rated as an Elite provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Synovial Sarcoma, Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.

Nicholas P. Webber
Advanced in Myxoid Liposarcoma
Dr. Nicholas P. Webber
Orthopedics
Advanced in Myxoid Liposarcoma
Dr. Nicholas P. Webber
Orthopedics

Aurora Orthopedics

2801 W Kinnickinnic River Pkwy, Ste 370, 
Milwaukee, WI 
414-649-7900
Languages Spoken:
English
See accepted insurances

Nicholas Webber is an Orthopedics provider in Milwaukee, Wisconsin. Dr. Webber is rated as an Advanced provider by MediFind in the treatment of Myxoid Liposarcoma. His top areas of expertise are Osteoarthritis, Osteonecrosis, Rhabdomyosarcoma Embryonal, Hip Replacement, and Knee Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Pamela E. Kaiser
Advanced in Myxoid Liposarcoma
Dr. Pamela E. Kaiser
Hematology | Oncology
Advanced in Myxoid Liposarcoma
Dr. Pamela E. Kaiser
Hematology | Oncology

Advocate Lutheran General Cancer Institute

1700 Luther Ln 1st & 2nd Fl, 
Park Ridge, IL 
847-268-8200
Languages Spoken:
English
See accepted insurances

Pamela Kaiser is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Kaiser is rated as an Advanced provider by MediFind in the treatment of Myxoid Liposarcoma. Her top areas of expertise are Angiosarcoma, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Endoscopy.

View All Doctors
What are the latest Myxoid Liposarcoma Clinical Trials?
A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma
A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. This study will test different doses of mirdametinib in combination with a fixed dose of palbociclib to find the best safe dose for further testing.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Pilot Study of BTX-A51 in Patients With Metastatic and/or Recurrent Liposarcomas Characterized by MDM2 Amplifications, Myxoid Liposarcoma, and CIC-Rearranged Sarcoma
A Pilot Study of BTX-A51 in Patients With Metastatic and/or Recurrent Liposarcomas Characterized by MDM2 Amplifications, Myxoid Liposarcoma, and CIC-Rearranged Sarcoma
Enrollment Status: Recruiting
Publish Date: October 31, 2025
Intervention Type: Drug
Study Phase: Phase 1

Summary: This study is testing two different doses of BTX-A51 to determine if it is safe and tolerable in participants with liposarcoma with MDM2 amplification, myxoid liposarcoma, and CIC-rearranged sarcoma. The name of the study drug used in this research study is: -BTX-A51 (a type of kinase inhibitor)

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center